The Role of P-Glycoprotein in the Pharmacokinetics and Tissue Distribution of a Hepatitis C Virus Protease Inhibitor

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|3|4|290-295

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.3, Iss.4, 2009-12, pp. : 290-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Pre-Clinical In Vitro and In Vivo Pharmacokinetics for the Selection of a Potent Hepatitis C Virus Protease Inhibitor, Boceprevir, for Clinical Development

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 4, 2009-06 ,pp. : 312-318

Bentham Science Publishers

Access to resources Recommend Favorite

Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications

By Lin J.H.   Yamazaki M.  

Clinical Pharmacokinetics, Vol. 42, Iss. 1, 2003-01 ,pp. : 59-98

Adis International

Access to resources Recommend Favorite

Modeling Methadone Pharmacokinetics in Rats in Presence of P-glycoprotein Inhibitor Valspodar

By Ortega Ignacio   Rodriguez Monica   Suarez Elena   Perez-Ruixo Juan   Calvo Rosario  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1299-1308

Springer Publishing Company

Access to resources Recommend Favorite

ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

By  

Current Medicinal Chemistry, Vol. 21, Iss. 28, 2014-09 ,pp. : 3261-3270

Bentham Science Publishers

Access to resources Recommend Favorite

Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

By  

Current Medicinal Chemistry, Vol. 16, Iss. 9, 2009-03 ,pp. : 1115-1121

Bentham Science Publishers

Access to resources Recommend Favorite